The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.EBI
Imperial College
Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.EBI
Chinese Academy of Sciences
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.EBI
G. D. Searle Research and Development
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.EBI
University of Dundee
3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.EBI
Second Military Medical University
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using EBI
Johannes Gutenberg-Universit£T Mainz
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.EBI
G.D. Searle And
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).EBI
Imperial College
Emerging New Targets for the Treatment of Resistant Fungal Infections.EBI
Second Military Medical University
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.EBI
Temple University
PYRIMIDINE COMPOUND AS WEE-1 INHIBITORBDB
Wigen Biomedicine Technology (Shanghai) Co.
Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.BDB
The M. S. University of Baroda
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.BDB
Mgi Pharma